Abstract
Bipolar, epilepsy and migraine disorders are frequently reported as co-morbid conditions. In this review article we highlight some of the similarities between these disorders, exploring at various levels including cellular, structural and phenotypic changes. Clinical observations suggest considerable overlap with a number of common neurobiological features. Nonetheless, the courses of development of each disorder remain to be elucidated such that there is much room for further research into their precise underlying mechanisms. A better understanding of the neurobiology of these disorders will help to improve current treatments, particularly when there is co-morbidity and presence of treatment resistant and complex cases.
Keywords: Bipolar disorder, comorbidity, depressive disorders, epilepsy, migraine, psychopharmacology.
Current Psychopharmacology
Title:Bipolar Affective Disorder, Epilepsy and Migraine – Does Possible Shared Pathogenesis Explain their Association?
Volume: 2 Issue: 2
Author(s): Jonathon Holland, Mark Agius and Rashid Zaman
Affiliation:
Keywords: Bipolar disorder, comorbidity, depressive disorders, epilepsy, migraine, psychopharmacology.
Abstract: Bipolar, epilepsy and migraine disorders are frequently reported as co-morbid conditions. In this review article we highlight some of the similarities between these disorders, exploring at various levels including cellular, structural and phenotypic changes. Clinical observations suggest considerable overlap with a number of common neurobiological features. Nonetheless, the courses of development of each disorder remain to be elucidated such that there is much room for further research into their precise underlying mechanisms. A better understanding of the neurobiology of these disorders will help to improve current treatments, particularly when there is co-morbidity and presence of treatment resistant and complex cases.
Export Options
About this article
Cite this article as:
Holland Jonathon, Agius Mark and Zaman Rashid, Bipolar Affective Disorder, Epilepsy and Migraine – Does Possible Shared Pathogenesis Explain their Association?, Current Psychopharmacology 2013; 2(2) . https://dx.doi.org/10.2174/2211556011302020001
DOI https://dx.doi.org/10.2174/2211556011302020001 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Pharmacology of Recombinant Low-Voltage Activated Calcium Channels
Current Drug Targets - CNS & Neurological Disorders Extracellular Vesicles in Glioblastoma: Role in Biological Processes and in Therapeutic Applications
Current Cancer Drug Targets The Four Human γ-Aminobutyric Acid (GABA) Transporters: Pharmacological Characterization and Validation of a Highly Efficient Screening Assay
Combinatorial Chemistry & High Throughput Screening Macrophage Derived Cystatin B/Cathepsin B in HIV Replication and Neuropathogenesis
Current HIV Research Flavonoids as Promising Lead Compounds in Type 2 Diabetes Mellitus: Molecules of Interest and Structure-Activity Relationship
Current Medicinal Chemistry Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Cell and Gene Therapies for Refractory Epilepsy
Current Neuropharmacology Drug-Resistance in Central Nervous System Tumors: From the Traditional Cell-Resistance Model to the Genetically Driven Approaches on Therapy
Current Pharmaceutical Biotechnology mTOR Inhibitors in Tuberous Sclerosis Complex
Current Neuropharmacology Insulin Growth Factor-I Promotes Functional Recovery After a Focal Lesion in the Dentate Gyrus
CNS & Neurological Disorders - Drug Targets Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article
CNS & Neurological Disorders - Drug Targets Decreased Valproate Level Caused by VPA-glucuronidase Inhibition by Carbapenem Antibiotics
Drug Metabolism Letters Lexical Characterisation of Bio-Ontologies by the Inspection of Regularities in Labels
Current Bioinformatics The Multiple Roles of Vitamin D in Human Health. A Mini-Review
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Mutual Interaction Between Sleep and Epilepsy on the Neurobiological Basis and Therapy
Current Neuropharmacology Astrocyte`s RAGE: More Than Just a Question of Mood
Central Nervous System Agents in Medicinal Chemistry Cytochrome P450s: Mechanisms and Biological Implications in Drug Metabolism and its Interaction with Oxidative Stress
Current Drug Metabolism Biological Signatures of Alzheimer’s Disease
Current Topics in Medicinal Chemistry Development and Validation of 'Level A' In Vitro - In Vivo Correlation for Extended Release Tablets of Lamotrigine
Current Bioactive Compounds Synthesis and Biological Evaluation of a New Series of Benzothiazole-Benzothiadiazine Conjugates as Antibacterial Agents
Letters in Drug Design & Discovery